Graftys develops , manufactures and markets patented synthetic bone biomaterials, in particular new generations of resorbable calcium-phosphate cements designed for reconstructive orthopedic surgery.
Automatic translation

Activity area

  • MEDTECH
  • MATERIALTECH
  • HEALTHTECH
  • BIOTECH

Maturity stage

  • Mature

Key information

Year of creation

2005

Maturity stage

Mature

Total fundraising amount

2 000 000 €

Last round table level

Investment

Total fundraising amount

2 000 000 €

Maximum round table reached

Date Amount Investors Round table
30/11/2021
31/07/2022 2 000 000,00 €